Taltz 80 MG/ML autoinjectorml
Ended Awarded Last action
- Contract number
- SPE2DR26FP8RQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,478
Award facts
- Contract value 100% obligated
- $18,477.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $18,477.97 by the Defense Logistics Agency (DLA) on January 15, 2026, for the supply of Taltz 80 mg/ml autoinjector. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 16, 2026, and performance conducted at the awardee's Conshohocken facility. The delivery order is issued under Amerisourcebergen Drug Corp's parent company, Cencora, Inc. (doing business as Amerisourcebergen), which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031.
This award demonstrates the continued reliance on Amerisourcebergen's pharmaceutical distribution capabilities to support federal medical procurement needs, particularly for military and veteran healthcare systems. Taltz (ixekizumab) is a specialty medication used in the treatment of inflammatory conditions, reflecting the company's established role in supplying brand-name pharmaceuticals and specialized medical supplies across multiple therapeutic domains. The competitive, non-set-aside nature of this award, combined with Amerisourcebergen's substantial IDC with DLA, underscores the company's proven capability to efficiently fulfill government requirements for essential pharmaceutical commodities needed by military treatment facilities and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FP8RQ?
SPE2DR26FP8RQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FP8RQ worth?
The government has obligated $18,478 on SPE2DR26FP8RQ.
Is contract SPE2DR26FP8RQ an order under another contract?
Yes. SPE2DR26FP8RQ is a delivery order under SPE2DR25D3005, an indefinite delivery contract.
Was contract SPE2DR26FP8RQ competed?
The extent of competition for SPE2DR26FP8RQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award